Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer

Benzer Materyaller

• Investigation of the effect of the farnesyl protein transferase inhibitor R115777 on isoprenylation and intracellular signalling by the prostacyclin receptor
  Yazar:: O'Meara, Sarah J, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor
  Yazar:: Sparreboom, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways
  Yazar:: Dalenc, Florence, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Therapy Oncology Group RTOG 0411
  Yazar:: Crane, Christopher H., ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase
  Yazar:: Marcus, Adam I., ve diğerleri
  Baskı/Yayın Bilgisi: (2005)